Nebraska Cancer Specialists/Oncology Hematology West PC - MECC is a clinical research site located in Omaha, Nebraska, United States 68114.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC has participated in 51 clinical trials with 50 currently active.
Therapeutic areas: Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma.
Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC has 51 clinical trials on record, with 50 currently active. Their work covers Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma.
Yes — Nebraska Cancer Specialists/Oncology Hematology West PC - MECC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.